Trial Profile
Phase I trial of AUT00063 in young and elderly healthy adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Apr 2015
Price :
$35
*
At a glance
- Drugs AUT 00063 (Primary)
- Indications Hearing loss; Tinnitus
- Focus Adverse reactions
- Sponsors Autifony Therapeutics
- 14 Apr 2015 New trial record